The global pharmaceutical import market is in a period of stable growth. On the one hand, the globalization layout of European and American pharmaceutical companies further promotes the growth of pharmaceutical trade; On the other hand, the upgrading of the pharmaceutical industry in China and India will continuously expand the supply of more competitive pharmaceutical products, including research and manufacturing capabilities highlighted in pharmaceuticals, medical consumables, and other products. Global pharmaceutical importers will have more opportunities.

According to the IQVIA report, global pharmaceutical expenditures will be approximately $1.6 trillion in 2024, with a compound annual growth rate of 6.0% from 2019 to 2024. It is expected to grow at a rate of 6.6% from 2025 to 2028, and global pharmaceutical spending is expected to reach approximately $2.2 trillion by 2028. Factors driving the increase in spending include increased pharmaceutical use, new product launches, patent expiration, and increased use of biosimilars.

According to Tendata Global Trade Data, the Top 10 Countries in Terms of Pharmaceutical Imports are:

1. Vietnam：$3,418.95 million(28.60% )

2. Pakistan：$2,584.15 million(21.62% )

3. India：$1,545.05 million(12.93% )

4. Russia：$1,013.14 million(8.48% )

5. Philippines：$881.94 million(7.38% )

6. Uzbekistan：$521.45 million(4.36% )

7. Sri Lanka：$329.45 million(2.76% )

8. Nigeria：$301.28 million(2.52% )

9. Ukraine：$190.40 million(1.59% )

10. Tanzania：$180.44 million(1.51% )

Vietnam and Pakistan account for over 50% of the total, making them major importers of pharmaceuticals; India, Russia, and the Philippines form a second tier with stable demand; Although Uzbekistan, Sri Lanka, Nigeria and other countries are relatively small in scale, they have shown certain growth potential, indicating that the pharmaceutical market still has room for development in emerging countries.

According to Tendata Global Trade Data, the Following Companies are the Largest Pharmaceutical Importers in 2024:

1. CÔNG TY CỔ PHẦN XUẤT NHẬP KHẨU Y TẾ VIỆT NAM(Vietnam，$242.86 million，5.24%)

Vietnam's largest pharmaceutical importer with a large procurement scale.

2. ASTRAZENECA INDUSTRIES LLC(Russia，$163.04 million，3.52%)

The Russian subsidiary of multinational pharmaceutical giant AstraZeneca has a high import volume and stable market demand.

3. SIGNET EXCIPIENTS PRIVATE LIMITED(India，$160.92 million，3.47%)

India's major raw material suppliers demonstrate that India is not only a pharmaceutical producing country, but also an important importer.

4. JSC SERVIER(Russia，$132.29 million，2.85%)

The Russian subsidiary of Sanofi Group in France has a large import scale, indicating a strong demand for foreign-funded pharmaceutical in the Russian market.

5. GETZ PHARMA PRIVATE LIMITED(Pakistan，$123.53 million，2.67%)

Pakistan's large pharmaceutical company has a considerable import volume.

6. CÔNG TY TNHH XNK AN PHÚ(Vietnam，$85.31 million，1.84%)

Vietnam's medium-sized pharmaceutical trading company has outstanding import volume, indicating its importance in the distribution of pharmaceutical imports.

7. CÔNG TY TNHH DEVESUN(Vietnam，$82.37 million，1.78%)

Another Vietnamese importer, with a scale close to An Ph ú, indicates fierce competition in the Vietnamese pharmaceutical market.

8. MERCK SHARP AND DOHME(Philippines，$69.63 million，1.50%)

The multinational pharmaceutical giant Merck's East Philippines branch has a high import volume, reflecting the influence of international pharmaceutical companies in Southeast Asia.

9. CÔNG TY TNHH ASTRAZENECA VIỆT NAM(Vietnam，$63.12 million，1.36%)

AstraZeneca's subsidiary in Vietnam has a stable import volume, indicating that foreign pharmaceutical companies are deeply rooted in the Vietnamese market.

10. CÔNG TY TNHH TOP BRANDS 68(Vietnam，$59.10 million，1.28%)

Vietnam's local pharmaceutical importer, although small in scale, has growth potential.

Vietnam is a major importer of pharmaceuticals and faces fierce market competition; The multinational pharmaceutical subsidiaries of Russia and India demonstrate their strong influence in the global pharmaceutical market; Enterprises in Pakistan and the Philippines highlight regional demands.

>>Get a Free Demo from Tendata<<

Tendata, as a leading provider of global trade data, maintains an extensive global trade database that spans numerous countries and industries, including the pharmaceutical import data.

For pharmaceutical importers, the Tendata Global Trade Data Platform delivers comprehensive market intelligence, reliable importer directories, and enhanced customer analysis to accelerate market expansion. By simply entering product keywords, businesses can quickly identify potential partners and gain access to detailed insights such as purchase volumes, transaction frequency, and recent buying trends—making it easier to target high-value customers effectively.